When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADAP - Why Adaptimmune Therapeutics Stock Sank and Then Quickly Rebounded Today
Adaptimmune Therapeutics plc
Shares of the clinical-stage biotech Adaptimmune Therapeutics(NASDAQ: ADAP) fell by as much as 11% immediately out of the gate Monday morning. The drugmaker's stock kicked off the week off on a sour note thanks to a fairly large public offering consisting of 12.5 million of its American depositary shares.
However, Adaptimmune has sharply rebounded as today's trading session has unfolded: As of 11:44 a.m. EDT, the biotech's stock is currently up by 19%.